A Controlled Comparison of Human and AI-Assisted Automated Revision of Delphi Statements on RNA-Based Medicines: Parallel, 2-Arm Study - Summary - MDSpire
Advertisement
A Controlled Comparison of Human and AI-Assisted Automated Revision of Delphi Statements on RNA-Based Medicines: Parallel, 2-Arm Study
To compare consensus outcomes between manual revisions and AI-assisted revisions of subthreshold statements using retrieval-augmented generation (RAG) and multi-agent modules.
Approach:
Delphi Method: Utilized a structured technique for eliciting expert judgment and achieving consensus in the context of RNA-based therapeutics.
AI-Assisted Pipeline: Implemented an AI-assisted Delphi pipeline to mirror human reviewer workflows in the post-round 1 phase.
Key Findings:
AI assistance is expected to rescue more statements by providing comprehensive evidence summaries and citation-anchored revisions.
Final consensus rates are anticipated to be similar to those achieved by human reviewers.
Interpretation:
Explorations of AI-facilitated Delphi exercises indicate potential for process acceleration while underscoring the importance of human oversight.
Limitations:
Delphi rounds are time-consuming, often taking 2 to 6 months.
Panelist engagement tends to decline with each round, complicating the formation of consensus.
Conclusion:
The study aims to evaluate the effectiveness of AI in enhancing the Delphi process for RNA-based therapeutics.